by John Moore | December 15, 2021
Looking Back: Reviewing Our 2021 Predictions
Chilmark’s 2021 predictions were mostly accurate, but could have been more daring. Our outlook on 2022 is forthcoming and will include some tougher calls.
Tag Archive: SaMD
by John Moore | December 15, 2021
Chilmark’s 2021 predictions were mostly accurate, but could have been more daring. Our outlook on 2022 is forthcoming and will include some tougher calls.
by Alex Lennox-Miller | January 30, 2020
Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. […]
John Moore · 3 weeks ago
Jody Ranck · 3 weeks ago
Jody Ranck · 7 days ago